Inactive Instrument

G9pharma co., LTD Stock

Equities

A078650

KR7078650009

Medical Equipment, Supplies & Distribution

Dynamic Chart
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023 CI
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2022 CI
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
G9pharma co., LTD Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
G9pharma co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
G9pharma co., LTD Reports Earnings Results for the Full Year Ended December 31, 2021 CI
G9pharma co., LTD cancelled the transaction announced on November 26, 2021 CI
G9pharma co., LTD announced that it has received KRW 9.9999984 billion in funding from Meritz Securities Co., Ltd., Investment Arm, Cypress Partners Co., Ltd. CI
G9pharma co., LTD announced that it has received KRW 5.999999573 billion in funding from Meritz Securities Co., Ltd., Investment Arm CI
G9pharma co., LTD announced that it expects to receive KRW 1.5 billion in funding from Cypress Partners Co., Ltd. CI
G9pharma co., LTD announced that it has received KRW 9.99999775 billion in funding from Meritz Securities Co., Ltd., Investment Arm CI
G9pharma co., LTD Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
More news
Managers TitleAgeSince
Chief Executive Officer 43 -
Chief Tech/Sci/R&D Officer 52 -
Comptroller/Controller/Auditor 71 -
Members of the board TitleAgeSince
Director/Board Member 65 -
Director/Board Member 53 -
Chief Executive Officer 43 -
More insiders
G9Pharma Co Ltd, formerly Kolen Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of aspherical optical lenses. The Company manufactures and sells lenses for camera optics and lenses for application optics. The Company's products are used in cell phone lenses, fingerprint recognition, smart wearable products, among others. In additional, the Company is engaged in the business of supplying vaccines, developing antibody drugs, developing protein products and others.
More about the company
  1. Stock Market
  2. Equities
  3. A078650 Stock